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Abstract 
Background: Vaginal colonization with group B Streptococcus (GBS) is the predominant risk factor for the develop-
ment of invasive neonatal GBS diseases and puts newborns at increased risk for morbidity and mortality. This study is 
aimed to determine the colonization rate and antimicrobial susceptibility pattern of group B Streptococcus among 
pregnant women.
Methods: Hospital based cross-sectional study was conducted from August to December 2014 at selected health 
facilities. A total of 139 antenatal clinics attendees, proportionally allocated, were recruited consecutively. Socio-
demographic and clinical factors were collected using a structured questionnaire. Vaginal swabs were collected and 
cultured on Todd Hewitt broth and in 5 % sheep blood agar. Antimicrobial susceptibility test was done using Kirby-
Bauer disk diffusion test. Statistical analysis was performed using Pearson’s Chi square test.
Results: Among the 139, 19 (13.7 %) were positive for GBS. All the GBS isolates were susceptible (100 %) to penicil-
lin G, vancomycin, ampicillin, erythromycin and gentamicin. Two of the GBS isolates showed multidrug resistance 
against norfloxacin and ciprofloxacin. No statistically significant difference was observed for GBS colonization with any 
independent variables.
Conclusion: Vaginal colonization of GBS for the present study put emphasis on further investigation and accom-
plishment of routine GBS screening practices. The recovery of resistant strains to antimicrobial agents recommended 
in cases of penicillin allergic mothers indicates the importance of susceptibility test.
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Background
Streptococcus agalactiae, group B streptococcus (GBS), is 
a species of the normal flora of the lower gastrointestinal 
and genitourinary tracts [1]. GBS is present in lower gen-
ital tract of 10–30 % pregnant women. When untreated, 
approximately 50–75  % of infants born to GBS positive 
mothers will become colonized [2].
GBS continues a significant cause of infection, mor-
bidity and mortality in newborns, pregnant and non-
pregnant women [3]. Vaginal colonization by GBS 
during pregnancy is associated with premature rupture 
of membrane, stillbirth and low birth weight babies [4]. 
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Colonization can be transient, chronic, or intermittent 
and the duration and rate of colonization varies [5, 6]. 
GBS is the most frequent cause of neonatal septicemia 
within few hours of birth and neonatal meningitis within 
few weeks of birth [3, 7].
There are two clinical syndromes of invasive GBS dis-
ease; early onset disease (EOD) and late onset diseases 
(LOD). EOD has a typical presentation of sepsis and 
pneumonia with in the first week of life and LOD pre-
senting most often with meningitis from day  >7 until 
3 months of age [6]. The fatality rate for infants with early 
onset GBS disease is estimated to be 4–6  %. Surviving 
infants may experience long-term disabilities including 
hearing loss, vision loss, or mental retardation [5, 7].
Detection of GBS in pregnant women is important for 
prompt and adequate treatment of neonatal meningitis 
and septicemia in newborns particularly for those who 
had low birth weight, premature delivery, premature rup-
ture of membrane and prolonged labor [8].
Implementation of prevention programs can decrease 
the morbidity and mortality rates resulting from GBS 
colonization and disease and it is more cost-effective to 
prevent GBS infection in the neonates than to treat GBS 
infections. Prevention and treatment strategies for GBS 
related diseases are based mainly on screening pregnant 
women in their third trimester and assessing exposing 
factors [9].
Prevention and treatment strategies have not yet been 
adopted in Ethiopia to manage maternal GBS coloniza-
tion, which will have a contribution in reducing neonatal 
infection by GBS. Therefore, evidences generated from 
operational researches that focus on determining the 
magnitude of GBS colonization, assessing the risk fac-
tors and drug susceptibility pattern of GBS to the com-
monly prescribed antibiotics is important in supporting 
and designing prevention strategies for the management 
of maternal colonization of GBS [10].
Published data on maternal colonization of GBS in 
Ethiopia is scarce [11, 12].Therefore, this study will have a 
great role in reducing infant and neonatal mortality rates, 
which are the main health indicators, will promote the 




A cross-sectional study was conducted from August to 
December 2014 in two selected health facilities Ayder 
Referral Hospital, (ARH) and Mekelle Health Center, 
MHC) of Mekelle city, that provide antenatal care (ANC) 
services. The city is located 783  km away from Addis 
Ababa, capital city of Ethiopia. Pregnant women (age 
18 and above) in the third trimester attending ANC in 
ARH and MHC were included. However, those pregnant 
women with history of antibiotic intervention 2  weeks 
prior to recruitment and those that were in the third 
trimester with  >37  weeks gestational age were excluded 
from the study.
Sample size and sampling technique
The sample size was calculated based on the colonization 
of GBS infection indicated in a study conducted in Gondar, 
North West Ethiopia, which was 9 % [12]. The actual sam-
ple required, was calculated using a standard formula
where n = the sample size to be determined.
Z α2 = the z-value at 95 % confidence interval = 1.96.
p = proportion of GBS colonization (pregnant women 
infected with GBS) 9 % = 0.09.
d = absolute sampling error (margin of error) that can 
be tolerated = 5 %.






The calculated sample size was allocated proportionally 
to each health facilities based on their average of preg-







× nt where n  =  the sample size to be 
allocated.
N1 = average number of ANC attendants per month in 
one health facility.















× 139 = 82 n2  =  ANC attendants in 
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Therefore, 57 and 82 participants were studied from 
























Page 3 of 8Alemseged et al. BMC Res Notes  (2015) 8:518 
Data source and data collection
A well-structured standard questionnaire with review 
of medical records was used to collect socio-demo-
graphic, risk factors and clinical characteristics of preg-
nant women attending ANC. Socio-demographic data 
like maternal age, residence, marital status, occupation, 
educational status; clinical data like gravidity, prenatal 
care, parity, urinary tract infection, outcomes of previous 
delivery, mode of delivery, prolonged rupture of mem-
brane, gestational age were collected.
Specimen collection, transportation
Following universal precautions vaginal swab was col-
lected by brushing the lower vagina with sterile cotton 
-tipped swab by trained midwives nurses [13]. The swabs 
were immediately placed into amies transport medium 
with charcoal and transported at room temperature to 
the Medical Microbiology laboratory of ARH within 
3–4 h for analysis and incase of unavoidable delay speci-
mens were stored at 4 °C for 24 h [14].
Culturing, isolation and identification of GBS
Vaginal Swabs were placed into 1.5  ml Todd-Hewitt 
broth (bioMerieux SA, France) supplemented with anti-
biotics incubated at 37  °C for 18–24 h and sub cultured 
on 5 % sheep blood agar with 5 % CO2 for 18–48 h. Fur-
thermore, sub cultured into nutrient agar by incubat-
ing overnight at 37 °C according to the Ethiopian Public 
Health Institute.
Presumptive identification of GBS was made by mor-
phology, Gram’s stain, catalase reaction, hemolytic activ-
ity on sheep blood agar plates Bacitracin sensitivity test 
and CAMP test [15]. Most strains of GBS produce grey 
mucoid colonies, surrounded by a small zone of beta-
haemolysis. All suspected GBS colonies (with narrow 
beta-hemolysis) was subcultured on nutrient agar and 
subjected for gram stain and catalase test. All gram posi-
tive and catalase negative cocci isolates were tested for 
Bacitracin sensitivity test and CAMP test was used as a 
confirmatory.
Antimicrobial susceptibility pattern
Antimicrobial susceptibility test was performed using 
the modified Kirby–Bauer disk diffusion method accord-
ing to the clinical laboratory standard institute guidelines 
[16]. The inoculums was prepared by suspending 4–5 iso-
lated colonies of the same morphology in 5 ml of sterile 
physiological saline equal to a 0.5 McFarland standards 
used as a reference to adjust the turbidity of bacterial 
suspensions. Swab was inoculated on Mueller–Hinton 
agar (MHA) plates supplemented with 5  % defibrinated 
sheep blood to obtain confluent growth, antibiotic disks 
was placed and incubated at 35–37  °C under 5  % CO2 
atmosphere for 20  h. The following antimicrobials were 
used with their respective concentration: penicillin G 
(P) (10  IU), ampicillin (AMP) (10  μg), erythromycin 
(E) (15  µg), gentamicin (CN) (10  µg), vancomycin (VA) 
(30  µg), norfloxacin (NOR) (10 μg), ciprofloxacin (CIP) 
(5  µg), ceftriaxone (CRO) (30  µg), and chloramphenicol 
(C) (30 µg) (Oxoid, UK).
Quality control
Standard operating procedures (SOPs) were followed 
during sample collection, transportation, and processing 
steps. The quality of the culture media and antimicrobial 
disks was checked using standard American Type Cul-
ture Collection (ATCC) reference strain of Staphylococ-
cus aureus ATCC 25923, Escherichia coli (ATCC 25922), 
S. agalactiae isolates (ATCC 12386).
Data processing and analysis
Statistical analysis was performed using SPSS version 
20.0. The statistical significant difference of GBS colo-
nization with independent variables was analyzed using 
inferential statistics to assess the significance of the data 
and results and Pearson’s Chi square test and P value 
were used to compute the statistical differences. P value 
less than 0.05 were used to consider statistically signifi-
cant difference in all analysis.
Ethical clearance
This study was ethically approved by Ethical Review 
Committee [Ref. No ERC 0452/2014]. College of Health 
Sciences, Mekelle University. Official cooperation let-
ters was obtained from Mekelle University and Tigray 
regional health bureau. Moreover, prior to conducting 
the study, the purpose and objective of the study was 
described to the participants and written consent was 
obtained from the study participants or guardians. All 
information of participants was kept confidential.
Results
Characteristics of the participants
A total of 139 pregnant women attending ANC service 
were recruited, with a response rate of 100 %. The mean 
age ± SD of the study participants were 26.1 ± 4.5 years, 
majority were in the age of 23–27  years (47.5  %). From 
the study participants 131 (94.2  %) were from urban 
areas. Majority of the study participants were married 
133 (95.7  %) and were housewives 62 (44.6  %). With 
regard to educational status a significant proportion, was 
completed secondary school 45 (32.4) (Table 1).
From the total participants, 83 (59.7  %) were multi-
gravida. The outcome of previous deliveries of the study 
subjects was normal healthy baby 70 (84.3 %) with vagi-
nal mode of delivery 74 (89.2  %). Majority of the study 
Page 4 of 8Alemseged et al. BMC Res Notes  (2015) 8:518 
participants were at 37  weeks of gestational age 59 
(42.4  %). Sixty-eight (48.9  %) of the study subjects had 
no vaginal nor ultrasound follow-up and 120 (86.3  %) 
were without history of urinary tract infection (UTI) 
(Table 2).
Vaginal GBS colonization
Of the 139 study participants 19 (13.7 %) were found pos-
itive for GBS. The frequency of GBS colonization among 
different age groups was not statistically significant (χ2; 
P  =  4.14; 0.39). All the GBS isolates were recovered 
from married pregnant mothers, but it was not statisti-
cally significant (χ2; P  =  0.99; 0.80). GBS carriage was 
found to be high 8 (42.1 %) in civil servants compared to 
other occupation groups. No statistical significant differ-
ence was observed in GBS carriage rate among pregnant 
women with occupational categories (χ2; P = 1.89; 0.76).
The carriage rate of GBS was highest among high grade 
completed 7 (36.8  %); However, not statistically signifi-
cant (χ2; P = 1.39; 0.71).
Among 19 GBS isolates, 13 (68.4 %) were multigravida. 
However, the difference in GBS colonization rate was not 
statistically significant (χ2; P  =  0.69; 0.41). Overall, no 
statistically significant difference was observed for GBS 
colonization in the study subjects with any of the socio-
demographic, clinical and behavioral characteristics 
mentioned below (Tables 3, 4).
Antibiotic susceptibility pattern
All GBS isolates (100 %) were susceptible to penicillin G, 
ampicillin, erythromycin, gentamicin and vancomycin. 
GBS isolates had intermediate susceptibility to Chloram-
phenicol 42.1 % (8/19 isolates), ceftriaxone 26.3 % (5/19 
isolates), ciprofloxacin 21.1 % (4/19 isolates) and norflox-
acin 15.8  % (3/19 isolates). 15.8  % (3/19) of the isolates 
showed multidrug resistance against norfloxacin and cip-
rofloxacin; 10.5 % (2/19) of them to two drugs. Low level 
of resistance was observed for norfloxacin 5.3  % (1/19) 
and ciprofloxacin 5.3 % (1/19) (Table 5).
Discussion
GBS is an important cause of infection in pregnant 
women and their newborns; however, there have been 
limited studies available in Ethiopia. When we compare 
our finding to other studies conducted outside of Ethio-
pia we found the maternal GBS colonization to be lower: 
in Poland 29.5  %, [17] 24  % in Belguim [18], 30.2  % in 
United States [19], 23 % in Saudi Arabia [20] and 16 % in 
Thailand [21]. This low detection rate might be due to the 
type of the specimen we use. Because the previous stud-
ies used a combination of rectal and vaginal swabs, this 
will increase GBS colonization. However, as compared to 
Table 1 Socio-demographic characteristics of  the study 
participants
*Waitress, Manual workers
Variables Category Frequency (n = 139) Percent (%)




Residence Urban 131 94.2
Rural 8 5.8




Occupation Student 9 6.5
Civil servant 44 31.7
House wife 62 44.6
Merchant 19 13.7
Others* 5 3.6
Educa. level Unable to read and 
write
15 10.8
Elementary (1–8) 37 26.6
Secondary (9–12) 45 32.4
High grade completed 42 30.2
Table 2 Clinical characteristics of the study participants
Variables Category Frequency 
(n = 139)
Percent (%)
Gravidity Primigravida 56 40.3
Multigravida 83 59.7








Neonatal death 4 4.8
Stillbirth 4 4.8
Spo. abortion 4 4.8
Premature 1 1.2
Mode of delivery Vaginal 74 89.2
Instrumental 4 4.8
Caesarean section 5 6.0
Gestational age 35 weeks 32 23.0
36 weeks 48 34.5
37 weeks 59 42.4






PROM Yes 5 3.6
No 134 96.4
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other studies 9.1 % in India [22] and 5.7 % in Israel [23]; 
the GBS colonization in this study is high. When we com-
pare our findings with other studies conducted in Africa: 
Our estimate of 13.7 % is lower than 25.3 % in Egypt [24], 
23 % in Tanzania [25] and higher than 9.8 % reported in 
Nigeria [26].
Relative to studies conducted in Ethiopia it is lower 
than 20.9  % reported in Hawassa, Southern Ethiopia 
[11] and higher than 9 % reported in Gondar, Northwest 
Ethiopia [12]. The low positivity rate of GBS colonization 
in this study area as compared to the study conducted in 
Hawassa might be due to the fact that we only took vagi-
nal swabs.
In this study, we tried to identify the risk factors associ-
ated to maternal GBS colonization. We consider possible 
risk factors such as, age, residence, marital status, occu-
pation, educational status, gravidity, paraty, gestational 
age, outcome of previous deliveries, mode of delivery, 
prenatal cares, GBS contributing diseases, Prolonged 
rupture of membrane >18 h, preterm labor (<37 weeks), 
maternal UTI in current pregnancy. However, none 
of them showed any statistically significant difference 
(P  >  0.05) with maternal GBS colonization. We tried to 
compare our study with other published findings on the 
association of risk factors. However, in a study conducted 
in Iran, preterm rupture of membrane were significantly 
different associated with GBS colonization (p  =  0.001) 
[27].
Knowing the antibiotics that are effective for the man-
agement of GBS colonization to the circulating GBS iso-
lates in the study setting will have important contribution 
in selecting antibiotics. We did the antimicrobial suscep-
tibility pattern of GBS isolates against 10 antimicrobial 
agents. In this study, GBS isolates were (100 %) suscepti-
ble to penicillin, ampicillin, gentamicin, vancomycin and 
erythromycin. In studies conducted on pregnant women, 
all isolates of GBS were found to be susceptible to peni-
cillin, ampicillin and vancomycin [3, 28]. Another study 
conducted in Da es Salaam, showed that 100  % suscep-
tibility to vancomycin and ampicillin [25]. However, a 
study conducted in Nigeria demonstrated susceptibility 
of ampicillin was only 70 % [29].
GBS isolates had intermediate susceptibility to Chlo-
ramphenicol, ceftriaxone, ciprofloxacin and norfloxacin. 
In a study employed in Egypt 7.89 % of the isolates were 
intermediate to erythromycin. The resistance pattern of 
GBS to ciprofloxacin and norfloxacin was 5.3  % (1/19) 
and 5.3  % (1/19) respectively [24]. However, in other 
studies, GBS isolates were 25  % and 41.9  % resistant to 
against erythromycin respectively [3, 28]. A study con-
ducted in Da es Salaam, Tanzania showed 100  % resist-
ance against gentamicin [25].
Table 3 GBS colonization versus socio-demographic characteristics
a Waitress, manual worker
Variables Category GBS result Total Pearson’s Chi square P value
Negative Positive
Age 18–22 25 4 29 1.32 0.73
23–27 55 11 66
28–32 28 3 31
33–37 12 1 13
Residence Urban 112 19 131 1.34 0.25
Rural 8 0 8
Marital status Married 114 19 133 0.99 0.80
Single 4 0 4
Divorced 1 0 1
Widowed 1 0 1
Occupation Student 8 1 9 1.89 0.76
Civil serva. 36 8 44
House wife 56 6 62
Merchant 16 3 19
Othersa 4 1 5
Education Unable to read and write 14 1 15 1.39 0.71
Primary 31 6 37
Secondary 40 5 45
High grade 35 7 42
Page 6 of 8Alemseged et al. BMC Res Notes  (2015) 8:518 
In this study we found resistant GBS isolates for chlo-
ramphenicol, erythromycin, ceftriaxone, ciprofloxacin 
and norfloxacin with few multi drug resistant (MDR) 
isolates. However in other studies conducted in south-
ern and Northern parts of Ethiopia showed that all 
GBS isolates were susceptible to penicillin, ampicillin, 
Table 4 GBS colonization versus clinical characteristics




Gravida Primigravida 50 6 56 0.69 0.41
Multigravida 70 13 83
Parity Nullipara 53 6 59 0.64 0.42
Primipara 35 11 46
Multipara 32 2 34
Outcome of previous deliveries Healthy baby 58 12 70 2.05 0.73
Neonatal death 4 0 4
Stillbirth 3 1 4
Spo. abortion 4 0 4
Premature 1 0 1
Mode of delivery Vaginal 63 11 74 4.54 0.10
Instrumental 2 2 4
CS 5 0 5
Gestational age 35 weeks 28 4 32 0.57 0.75
36 weeks 40 8 48
37 weeks 52 7 59
Prenatal care Ultrasound 21 4 25 0.48 0.92
Vaginal exam 8 1 9
Both of them 33 4 37
None of them 58 10 68
UTI Yes 15 4 19 1.02 0.31
No 105 15 120
GBS con. diseases Yes 3 0 3 0.02 0.96
No 117 19 136
PROM Yes 4 1 5 0.18 0.68
No 116 18 134
Duration of PROM <18 h 3 1 4 0.31 0.58
≥18 h 1 0 1
Table 5 Antibiotic susceptibility profile of GBS isolates
Antibiotic Susceptible Intermediate Resistant
Frequency (n = 19) Percent (%) Frequency (n = 19) Percent (%) Frequency (n = 19) Percent (%)
Penicillin 19 100 – – – –
Ampicillin 19 100 – – – –
Erythromycin 19 100 – – – –
Gentamycin 19 100 – – – –
Vancomycin 19 100 – – – –
Norfloxacin 15 78.9 3 15.8 1 5.3
Ceftriaxone 14 73.7 5 26.3 – –
Ciprofloxacin 14 73.7 4 21.1 1 5.3
Chloramphenicol 11 57.9 8 42.1 – –
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vancomycin and gentamicin. In general, our findings 
indicate the need to put emphasis on further investi-
gation and accomplishment of routine GBS screening 
practices.
Conclusions
In this study the overall prevalence of GBS coloniza-
tion among pregnant mothers attending Antenatal care 
(ANC) was 13.7 %. This might call for the implementa-
tion of routine GBS screening procedure of all pregnant 
women attending ANC. Moreover, we found a grow-
ing resistance of GBS to ciprofloxacin and norfloxa-
cin. Therefore, further epidemiological studies should 
be conducted in order to assess the GBS colonization 
rate among pregnant women and drug susceptibility 
pattern, which will aid to put into practice antibiotics 
prophylaxis.
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